MAHA Summit 2026: what today's health summit means — and the credibility fight
Today in Washington, D.C., the second MAHA Summit convenes at the Waldorf-Astoria — 9 AM to 5:30 PM ET, livestreamed free — with Vice President JD Vance and HHS Secretary Robert F. Kennedy Jr. closing the day in a fireside chat. The agenda is stacked with sessions that touch the roots of cellular health: food-as-medicine, sleep science, cancer prevention and early detection, longevity, and AI in medicine. But the summit arrives with a credibility fight: grassroots activists say corporate sponsors have captured the movement.
What's on the agenda
Panels include USDA Secretary Brooke Rollins on securing the food supply, a “Recovery First” session on the science of sleep, an FDA-modernization panel with acting FDA Commissioner Kyle Diamantas and CMS Administrator Dr. Mehmet Oz, a cancer-prevention panel with GRAIL's CEO on early detection, and “The MAHA Athlete” with Mike Tyson, Michael Chandler, and Gary Brecka. The throughline: chronic disease starts upstream — in food, sleep, environment, and early detection — the same upstream where mitochondrial health lives.
The backlash
Not everyone is celebrating. Regenerative-farming advocate Kelly Ryerson told the Washington Examiner the lineup “does not reflect the issues that birthed the original MAHA movement” — “I don't recognize this version of MAHA.” Dr. Robert Malone called the sponsorship “sickening.” Sponsors include Walmart, Hims & Hers, Noom, OpenAI, Anthropic, UnitedHealth, and Elevance; Politico previously reported that speaking slots were offered to companies willing to pay tens of thousands of dollars.
Why it matters for your cells
Strip away the politics and the summit's core premises are cellular: ultra-processed food, poor sleep, and late-detected disease all converge on mitochondrial dysfunction. The movement can point to real wins — 42 states advancing MAHA legislation, companies representing 40% of the food industry committing to remove artificial dyes, $1.8 billion a year redirected to childhood chronic disease. Whether it can advance those goals while taking money from the industries it was built to challenge is the question worth watching — today and after.
Where the evidence stands
- Established: The summit's date, venue, headliners, agenda, and sponsor list are published by organizers and reported by multiple outlets; activist criticisms are on-the-record quotes.
- Preliminary: Whether summit commitments translate into policy or health outcomes.
- Contested: Whether corporate sponsorship compromises the movement's independence — activists and organizers disagree.
- Absent: No summit session explicitly addresses mitochondrial health by name.